Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571259 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Antimicrobial Catheter Lock
A Phase 4 study, sponsored by Satellite Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 303
- Enrollment target
NCT00571259: Completed Phase 4 study, sponsored by Satellite Healthcare.
NCT00571259 is a Phase 4 study that has completed, run by Satellite Healthcare. The registered enrollment target is 303 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (42% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00571259, a Phase 4 study, has completed, sponsored by Satellite Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 303 participants
- Enrollment target
Study Summary
This is a randomized, double blinded, prospective, multicenter, clinical trial of the use of Heparin versus Gentamicin as a pos-dialysis catheter lock solution.
Primary Outcome
Positive blood cultures in a patient whose vascular access is a central venous catheter without another obvious source of infection
Interventions
- DRUG Heparin 1000U/mL
- DRUG 4% Sodium Citrate with Gentamicin 320 mcg/mL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 303 participants |
| Start Date | 2003-09 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
What the finished NCT00571259 record still lists
NCT00571259 is an interventional study that assigns participants to a tested intervention. The registered 303 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (42% lower).
The record links to 0 conditions, and to 2 interventions - of which Heparin 1000U/mL is the first listed.
NCT00571259 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00571259 about?
NCT00571259 is a clinical study titled "Prophylactic Antimicrobial Catheter Lock". This is a randomized, double blinded, prospective, multicenter, clinical trial of the use of Heparin versus Gentamicin as a pos-dialysis catheter lock solution.
What is the current status of trial NCT00571259?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 303 participants. The study started on 2003-09. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00571259?
The interventions under investigation include: Heparin 1000U/mL (DRUG), 4% Sodium Citrate with Gentamicin 320 mcg/mL (DRUG).
Who is sponsoring clinical trial NCT00571259?
This trial is sponsored by Satellite Healthcare, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00571259's enrollment target sits among peer trials
303 266th of 2000 higher than 1,735 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05508971 · 303 participants · NA
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia